Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2022 FY- Text added to 2023 FY
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. freshman Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
New words:
back, Edit, Graph, Sativusin
Removed:
abroad, AdventHealth, advisor, Africa, agriculture, analyzing, anticancer, anticipate, ASGE, author, aviv, biomedical, BMT, Brigham, career, charter, cholangiopancreatography, communicate, construction, Council, defend, directing, EMEA, endoscopy, ERCP, EUS, extensively, Faculty, fellowship, Florida, founded, ft, gastro, genomic, graduating, Gsap, Halpern, Harvard, Hematology, Hong, India, innovation, Interventional, Japan, justified, Khaimah, Kong, managed, manager, master, Mexico, MHA, Microbiome, MIT, Modulation, MOH, multicenter, NTT, Nutrition, OSD, page, Parenteral, PDA, Pediatric, PhD, portfolio, PR, preforming, president, Prof, proficient, Profiling, published, Ras, Recannati, retrograde, Sackler, school, Sigalit, solid, South, spearheaded, specialist, sq, standing, Taro, Technion, tel, Teva, Tokyo, Toren, travel, UAE, ultrasound, unicenter, Utility, Vice, Women, Zamir
Valuein 2022 FY filing- Value in 2023 FY filing
Original filings
Filing view